Trademark: 88074194
Status Date
Tuesday, April 14, 2020
Registration Number
6031814
Registration Date
Tuesday, April 14, 2020
Filing Date
Friday, August 10, 2018
Published for Opposition
Tuesday, July 16, 2019
5 Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; none of the foregoing goods for use in connection with the treatment or prevention of ear disorders
42 Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies
Apr 14, 2020
Registered-Principal Register
Mar 7, 2020
Ttab Release Case To Trademarks
Mar 7, 2020
Opposition Terminated No. 999999
Mar 7, 2020
Opposition Dismissed No. 999999
Jan 13, 2020
Opposition Instituted No. 999999
Nov 20, 2019
Changes/Corrections After Pub Approval Entered
Nov 18, 2019
Assigned To Petition Staff
Oct 22, 2019
Teas Post Publication Amendment Received
Jul 22, 2019
Extension Of Time To Oppose Received
Jul 16, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 16, 2019
Published For Opposition
Jun 26, 2019
Notification Of Notice Of Publication E-Mailed
Jun 12, 2019
Approved For Pub - Principal Register
Jun 10, 2019
Examiner's Amendment Entered
Jun 10, 2019
Notification Of Examiners Amendment E-Mailed
Jun 10, 2019
Examiners Amendment E-Mailed
Jun 10, 2019
Examiners Amendment -Written
Jun 1, 2019
Teas/Email Correspondence Entered
May 31, 2019
Correspondence Received In Law Office
May 31, 2019
Teas Response To Office Action Received
Dec 4, 2018
Notification Of Non-Final Action E-Mailed
Dec 4, 2018
Non-Final Action E-Mailed
Dec 4, 2018
Non-Final Action Written
Nov 28, 2018
Assigned To Examiner
Nov 20, 2018
Applicant Amendment Prior To Examination - Entered
Nov 15, 2018
Teas Voluntary Amendment Received
Sep 18, 2018
Applicant Amendment Prior To Examination - Entered
Sep 18, 2018
Assigned To Lie
Sep 9, 2018
Teas Voluntary Amendment Received
Aug 20, 2018
New Application Office Supplied Data Entered In Tram
Aug 14, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
